ESOT Virtual

Direct Access Request
Access to this content is restricted only to the registered delegates of the ESOT Congress 2023.
It is also possible to purchase on-demand access.
1.1 VIDEO LECTURE
Congress delegate:  Please request a direct access link here
Non-delegate:  It is also possible to purchase on-demand access, click here to create an account.
BCL-6 INHIBITORS POTENTLY INHIBIT ALLOGENEIC T CELL ACTIVATION - A NOVEL MECHANISM OF IMMUNOSUPPRESSION?
Louisa Steines
Louisa Steines
ESOT Virtual. Steines L. 09/18/2023; 397490; LDV1
user
Louisa Steines

What's new

As we look back and reflect on a resounding congress, join us in re-living the success of this event by reading the ESOT Congress 2023 Review. Containing some of the most memorable moments of the congress, this review will divulge some of the best scientific highlights and recognise our award winners, giving you the chance to catch up on what you missed and experience even more…

About Us

The European Society for Organ Transplantation (ESOT) was founded 40 years ago and is dedicated to the pursuit of excellence in organ transplantation. Facilitating a wealth of international clinical trials and research collaborations over the years, ESOT remains committed to its primary aim of improving patient outcomes in transplantation.
2025 ©
The European Society for Organ Transplantation
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies